Invesco Oppenheimer Intl Sml-Mid Com R5 (INSLX)

50.11 +0.39  +0.78% Dec 4 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 50.11
Turnover Ratio 28.00%
1 Year Fund Level Flows -1.572B

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.56% 1.81% 45
3M 7.35% 8.61% 58
6M 7.53% 9.13% 77
YTD 4.18% 22.34% --
1Y -- 12.38% --
3Y -- 11.55% --
5Y -- 7.17% --
10Y -- 8.64% --
15Y -- 7.63% --
20Y -- 6.41% --
As of Dec. 4, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.94% 0.94% 0.00%
Stock 99.07% 99.07% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other -0.01% 0.03% 0.04%
As of Sept. 30, 2019

Region Exposure

Americas 16.68%
North America 16.66%
Latin America 0.02%
Greater Europe 58.01%
United Kingdom 18.07%
Europe Developed 35.14%
Europe Emerging 0.41%
Africa/Middle East 4.39%
Greater Asia 25.30%
Japan 23.17%
Australasia 2.11%
Asia Developed 0.03%
Asia Emerging 0.00%
Market Classification
% Developed Markets 99.56%
% Emerging Markets 0.44%
As of Sept. 30, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 6.10%
Communication Services 0.00%
Consumer Cyclical 6.50%
Consumer Defensive 8.87%
Energy 0.02%
Financial Services 5.82%
Healthcare 26.59%
Industrials 15.55%
Real Estate 0.76%
Technology 29.76%
Utilities 0.02%
As of Sept. 30, 2019

Stock Market Capitalization

Giant 0.00%
Large 10.83%
Medium 63.45%
Small 20.89%
Micro 4.83%
As of Sept. 30, 2019

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.39%
Large Cap Growth 10.73%
Mid Cap Value 4.18%
Mid Cap Blend 12.46%
Mid Cap Growth 46.54%
Small Cap Value 2.80%
Small Cap Blend 2.51%
Small Cap Growth 20.39%
As of Sept. 30, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
NICE NICE Ltd ADR 4.33% 145.80 -0.16%
AFX Carl Zeiss Meditec AG 2.97% -- --
NKTR Nektar Therapeutics Inc 2.62% 20.01 -1.40%
4684 OBIC Co Ltd 2.45% -- --
ASM ASM International NV 2.21% -- --
OSSR Ossur hf 2.09% -- --
SEDG SolarEdge Technologies Inc 2.01% 87.39 +0.98%
TECN Tecan Group Ltd 1.89% -- --
OCDO Ocado Group PLC 1.77% -- --
CAE.TO CAE Inc 1.66% 34.70 +0.12%
As of Sept. 30, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks capital appreciation. Under normal market conditions, the fund will invest at least 80% of its net assets, plus borrowings for investment purposes, in equity securities of small- and mid-cap companies, and in derivatives and other instruments that have economic characteristics similar to such securities. The fund's manager considers small- and mid-cap companies to be those having a market capitalization in the range of the MSCI All Country World (ACWI) ex-U.S. SMID Index. The capitalization range of the index is subject to change at any time due to market activity or changes in its composition.
General
Security Type Mutual Fund
Oldest Share Symbol OSMAX
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class International Equity
Broad Category Equity
Category Name Foreign Small/Mid Growth
Prospectus Objective Growth
Fund Owner Firm Name Invesco
Reports
One Page Report Download

Manager Info

Name Tenure
David Nadel 0.00 yrs
Frank Jennings 1.09 yrs

Share Classes

Symbol Share Class
OSCIX Inst
OSMAX A
OSMCX C
OSMNX Retirement
OSMYX Inst

Net Fund Flows

1M -108.92M
3M -272.00M
6M -547.80M
YTD -1.215B
1Y -1.572B
3Y -1.137B
5Y 2.111B
10Y 2.811B
As of Nov. 30, 2019

Risk Info

Beta (5Y) --
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) --
Daily Value at Risk (VaR) 1% (All) 2.47%
Monthly Value at Risk (VaR) 1% (All) 6.09%

Fundamentals

Dividend Yield TTM (12-4-19) 0.00%
30-Day SEC Yield --
7-Day SEC Yield (12-2-19) 0.00%
Weighted Average PE Ratio 26.17
Weighted Average Price to Sales Ratio 1.802
Weighted Average Price to Book Ratio 3.158
Weighted Median ROE 11.78%
Weighted Median ROA 5.28%
Forecasted Dividend Yield 1.33%
Forecasted PE Ratio 24.08
Forecasted Price to Sales Ratio 1.760
Forecasted Price to Book Ratio 2.155
Number of Holdings 126
As of Sept. 30, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 12.54%
Forecasted Book Value Growth 8.65%
Forecasted Cash Flow Growth -7.99%
Forecasted Earnings Growth 16.07%
Forecasted Revenue Growth -8.71%
As of Sept. 30, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment 1.00M USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.91%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 5/24/2019
Termination Date
Last Annual Report Date 8/31/2019
Last Prospectus Date 5/25/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.